Brief: Strides Pharma Science Proposes To Consolidate Group's South African Business Under Trinity Pharma (Proprietary), South Africa
29/03/2024 15:12
March 29 (Reuters) - Strides Pharma Science Ltd
SRID.NS :
* STRIDES PHARMA SCIENCE LTD - PROPOSES TO CONSOLIDATE
GROUP'S
SOUTH AFRICAN BUSINESS UNDER TRINITY PHARMA (PROPRIETARY)
LIMITED, SOUTH AFRICA
Source text for Eikon: ID:nBSE15mLyg
Further company coverage: SRID.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Strides Pharma Science
See all newsIndia's Strides Pharma jumps on successful closure of USFDA inspection at Bengaluru facility
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees